Literature DB >> 11062489

Immunotherapy of human cancer: lessons from mice.

P K Srivastava1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062489     DOI: 10.1038/808795

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  32 in total

1.  The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.

Authors:  T Matsutake; P K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Heat shock proteins: the fountainhead of innate and adaptive immune responses.

Authors:  S Basu; P K Srivastava
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

Review 3.  Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe?

Authors:  Tangchun Wu; Robert M Tanguay
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 4.  "It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.

Authors:  Matthew R Buckwalter; Pramod K Srivastava
Journal:  Semin Immunol       Date:  2008-08-20       Impact factor: 11.130

5.  Surface binding and uptake of heat shock protein 70 by antigen-presenting cells require all 3 domains of the molecule.

Authors:  Christine Zimmer; Tamás Henics
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

6.  Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.

Authors:  Qin-Long Gu; Xue Huang; Wen-Hong Ren; Lei Shen; Bing-Ya Liu; Si-Yi Chen
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity.

Authors:  Lifeng Wang; Lisa Rollins; Qinlong Gu; Si-Yi Chen; Xue F Huang
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

8.  Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.

Authors:  Michal Kuczma; Magdalena Kopij; Iwona Pawlikowska; Cong-Yi Wang; Grzegorz A Rempala; Piotr Kraj
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

9.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.

Authors:  David M Koelle; Amalia Magaret; Christopher L McClurkan; Michael L Remington; Terri Warren; Florentina Teofilovici; Anna Wald
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

Review 10.  Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.

Authors:  Gunver S Kienle; Anja Glockmann; Michael Schink; Helmut Kiene
Journal:  J Exp Clin Cancer Res       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.